The Patent Finder

King Pharmaceuticals Research and Development, Inc.

Also on record
Records under this name other than patents King Pharmaceuticals Research and Development, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to King Pharmaceuticals Research and Development, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,714,006Methods of modifying the bioavailability of metaxalone
Term ended
Term ended Jan 14, 2025 · USPTO record
Term endedTerm ended Jan 14, 2025USPTO record
US 7,005,416Dalfopristine/Quinupristine Combinations with Cefpirome
Term ended
Term ended Aug 10, 2022 · High confidence
Term endedTerm ended Aug 10, 2022High confidence
US 6,555,581Levothyroxine compositions and methods
Term ended
Term ended Feb 15, 2022 · USPTO record
Term endedTerm ended Feb 15, 2022USPTO record
US 7,067,148Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
Term ended
Term ended Feb 15, 2022 · USPTO record
Term endedTerm ended Feb 15, 2022USPTO record
US 6,407,128Method for increasing the bioavailability of metaxalone
Term ended
Term ended Dec 3, 2021 · USPTO record
Term endedTerm ended Dec 3, 2021USPTO record
US 6,683,102Methods of using metaxalone in the treatment of musculoskeletal conditions
Term ended
Term ended Dec 3, 2021 · USPTO record
Term endedTerm ended Dec 3, 2021USPTO record
US 6,248,774Method for treating hyper-excited sensory nerve functions in humans
Term ended
Term ended Sep 5, 2020 · USPTO record
Term endedTerm ended Sep 5, 2020USPTO record
US 6,187,746Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof
Term ended
Term ended Dec 15, 2018 · USPTO record
Term endedTerm ended Dec 15, 2018USPTO record
US 7,271,171Adenosine A3 receptor modulators
Term ended
Term ended Oct 1, 2018 · USPTO record
Term endedTerm ended Oct 1, 2018USPTO record
US 6,407,236Adenosine A3 receptor modulators
Term ended
Term ended Sep 16, 2018 · USPTO record
Term endedTerm ended Sep 16, 2018USPTO record
10 of 42 patents shown.
Pro members see all 42.
Pro members: see all 42 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited